주요우울증에서 사이토카인-세로토닌 상호작용에 의한 신경변성 가설

키워드

참고문헌 (79)

1. "Basic concepts in the study of diseases with complexgenetics", 45, pp.522~532 (1999)
2. "The role of childhood trauma in the neurobiologyof mood and anxiety disorders:preclinical and clinicalstudies", 49, pp.1023~1039 (2001)
3. "The impact of early adverse experiences onbrain systems involved in the pathophysiology of anxiety and affectivedisorders", 46, pp.1509~1522 (1999)
4. "The catecholamine hypothesis of affective disorders:a review of supporting evidence", 122, pp.509~522 (1965)
5. "Serotonin and the neurobiology of depression.Effects of tryptophan depletion in drug-free depressed patients", 51, pp.865~874 (1994)
6. "Synaptic plasticity and mood disorders", 7, pp.29~34 (2002)
7. "Regulation of adult neurogenesisby antidepressant treatment", 25, pp.836~844 (2001)
8. "Neurobiology of depression", 34, pp.13~25 (2002)
9. "Neuroimaging abnormalities in the amygdala in mooddisorders", 985, pp.420~444 (2003)
10. "The role of cytokine network in psychologicalstress", 15, pp.148~155 (2003)
11. "Cytokines and the central nervous system", 54, pp.329~338 (2001)
12. "Role of the cytokine network in the CNS and psychiatricdisorders", 68, pp.11~20 (1997)
13. "The role of inflammatory mediators in the biologyof major depression:central nervous system cytokines modulatethe biological substrate of depressive symptoms,regulate stressresponsivesystems,and contribute to neurotoxicity and neuroprotection", 4, pp.317~327 (1999)
14. "The monocyte-T-lymphocyte hypothesisof major depression", 20, pp.111~116 (1995)
15. "Depression,stress and immunological activation:the role of cytokines in depressive disorders", 62, pp.583~606 (1998)
16. "Theplasma levels of interleukin-12 in schizophrenia,major depression,and bipolar mania:effects of psychotropic drugs", 7, pp.1107~1114 (2002)
17. "The role of cytokines in depression and their therapeuticimplication", 11, pp.304~312 (2000)
18. "Increased synthesisof IL1beta in Monocytes by examination stress", 38, pp.1502~1510 (1999)
19. "Cytokine-serotonin interaction through IDO:A neurodegeneration hypothesis of depression", 61, pp.519~525
20. "The serotonin hypothesis of major depression .The foutrh Generation of Progress.", pp.933~944 (1995), Raven Press
21. "Receptor sensitivity andthe mechanism of action of antidepressant treatment.Implicationsfor the etiology and therapy of depression", 38, pp.1160~1180
22. "Decreased plasma tryptophan concentration in majordepression:relationship to melancholia and weight loss", 20, pp.185~191 (1990)
23. "Tryptophan depletion causesa rapid lowering of mood in normal males", pp.173~177 (1985), Smith SE
24. "Enhancement of the antidepressant response to L-tryptophanby a liver pyrrolase inhibitor:a rational treatment approach", 4, pp.188~192 (1978)
25. "Role of 5-HT in stress,anxiety,and depression", 54, pp.129~141 (1996)
26. "Roleof somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission", 861, pp.204~216 (1998)
27. "How long should pindolol be associated with paroxetine toimprove the antidepressant response?", 17, pp.446~450 (1997)
28. "Controlof dorsal raphe 5-HT function by multiple 5-HT(1)autoreceptors: parallel purposes or pointless plurality?", 23, pp.459~465 (2000)
29. "Interaction of serotonin autoreceptor antagonistsin the rat dorsal raphe nucleus:an in vitro fast cyclic voltammetrystudy", 300, pp.45~48 (2001)
30. "Serotonergic responsivity in obsessive-compulsive disorder.Comparisonof patients and healthy controls", 44, pp.946~951 (1987)
31. "Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putativeindex of 5-HT2C", 2B receptor function, 1994, pp.33, 1581~1588
32. "Recent developments in thepsychobiology and pharmacotherapy of depression:optimising existingtreatments and novel approaches for the future", 12, pp.65~86 (2003)
33. "Regulation of serotonin1A and mineralocorticoidreceptor in rat and human hippocampus: implications for theneurobiology of depression", 43, pp.547~573 (1998)
34. "Is there a role for 5-HT1A agonists in the treatmentof depression?", 53, pp.193~203 (2003)
35. "Cultured sympathetic neuronssynthesize and release the cytokine interleukin 1 beta", 89, pp.10440~10443 (1992)
36. "Interleukin-1 immunoreactiveinnervation of the human hypothalamus", 240, pp.321~324 (1988)
37. "Distributionand characterization of tumor necrosis factor-alpha-like immunoreactivityin the murine central nervous system", 337, pp.543~567
38. "Cytokine-induced changes in mood and behaviour:implications for ‘depression due to a general medical condition’,immunotherapy and antidepressive treatment.", 5, pp.389~399 (2002)
39. "Mood and cognitive disorders in cancer patients receivingcytokine therapy", 461, pp.75~81 (1999)
40. "Mechanisms of the behavioural effects of cytokines", 461, pp.83~105 (1999)
41. "Changes in the immune system in depression anddementia:causal or co-incidental effects?", 19, pp.305~312 (2001)
42. "Interleukin 1 stimulates the secretion of hypothalamic corticotropin-releasingfactor", 238, pp.522~524 (1987)
43. "Corticotropin-releasing factor-producing neurons in the rat activatedby interleukin-1", 238, pp.524~526 (1987)
44. "Relationships between interleukin-6 activity,acute phaseproteins,and function of the hypothalamic-pituitary-adrenal axisin severe depression", 49, pp.11~27 (1993)
45. "IFN-beta1b induces kynurenine pathway metabolismin human macrophages:potential implications for multiplesclerosis treatment", 21, pp.1097~1101 (2001)
46. "Cytokines induce indoleamine2,3-dioxygenase expression in human atheroma-asociatedcells:implications for persistent Chlamydophila pneumoniaeinfection", 70, pp.3959~3961 (2002)
47. "Is there evidence for an effect of antidepressantdrugs on immune function?", 461, pp.267~281 (1999)
48. "Negative immunoregulatory effects of antidepressants:inhibition ofinterferon-gamma and stimulation of interleukin-10 secretion", 20, pp.370~379 (1999)
49. "Tricyclic antidepressants inhibitIL-6,IL-1 beta and TNF-alpha release in human blood monocytesand IL-2 and interferon-gamma in T cells", 34, pp.27~37 (1996)
50. "Induction ofinterleukin-1 beta and interleukin-1 receptor antagonist mRNA bychronic treatment with various psychotropics in widespread area ofrat brain", 215, pp.201~204 (1996)
51. "Role of corticotropin-releasing factor in immunosuppression", 104, pp.238~247 (1991)
52. "Effects of cytokines on glucocorticoidreceptor expression and function.Glucocorticoid resistanceand relevance to depression.", 461, pp.107~116 (1999)
53. "Interleukin-2 and -6 induce behavioral-activating effects in mice", 811, pp.111~121 (1998)
54. "Major depression and activation of the inflammatory responsesystem", 461, pp.25~46 (1999)
55. "Effects ofserotonin and serotonergic agonists and antagonists on the productionof interferon-gamma and interleukin-10", 23, pp.89~98 (2000)
56. "Effects of interferon-gamma,interleukin-1beta,tumornecrosis factor-alpha on the serotonin metabolism in the nucleusraphe dorsalis of the rat", 104, pp.981~991 (1997)
57. "Regulation of the human serotonin transporterby interleukin-1 beta", 216, pp.560~567 (1995)
58. "Implications of interferon-induced tryptophan catabolism in cancer,auto-immune diseases and AIDS", 294, pp.425~435 (1991)
59. "Altered tryptophan and neopterin metabolism in cancer patientstreated with recombinant interleukin 2", 49, pp.4941~4944 (1989)
60. "Relapse of depression afterrapid depletion of tryptophan", 349, pp.915~919 (1997)
61. "Human macrophages convert Ltryptophaninto the neurotoxin quinolinic acid", 283, pp.633~635 (1992)
62. "Tryptophan catabolism and T-cell tolerance:immunosuppression by starvation?", 20, pp.469~473 (1999)
63. "Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell linesindependently from interferon-gamma", 22, pp.931~936 (2002)
64. "Antioxidants inhibit indoleamine 2,3-dioxygenase in IFNgamma-activated human macrophages:posttranslational regulationby pyrrolidine dithiocarbamate", 166, pp.6332~6340 (2001)
65. "Transcriptional activation of indoleaminedioxygenase by interleukin 1 and tumor necrosis factor alpha ininterferon-treated epithelial cells", 12, pp.588~594 (2000)
66. "anendogenous metabolite that produces axon-sparing lesions in ratbrain", qui(linic acid), pp.316~318
67. "An iontophoretic investigation of the actionsof convulsant kynurenines and their interaction with theendogenous excitant quinolinic acid", 247, pp.184~187 (1982)
68. "On the role of metabotropic glutamate receptorsin the mechanisms of action of antidepressants", 54, pp.581~586 (2002)
69. "Neuroprotective properties of tianeptine:interactionswith cytokines", 44, pp.801~809 (2003)
70. "The rationale for long-term antidepressant therapy", 8, pp.225~235 (1993)
71. "Depression and Parkinson’s disease:a new look at an oldproblem", 16, pp.39~48 (2002), Depress Anxiety
72. "Post stroke depression:epidemiology,pathophysiology,and biological treatment", 52, pp.253~264 (2002)
73. "Depression and functional statusas predictors of death among cancer patients", 94, pp.2719~2727 (2002)
74. "Cytokine-serotonin interaction through IDO:A neurodegeneration hypothesis of depression", 61, pp.519~525 (2003)
75. "Depression durationbut not age predicts hippocampal volume loss in medicallyhealthy women with recurrent major depression", 19, pp.5034~5043 (1999)
76. "Hippocampal volume reduction in major depression", 157, pp.115~118 (2000)
77. "The neurobiology of stress:from serendipity to clinicalrelevance", 886, pp.172~189 (2000)
78. "Stress induces atrophy of apicaldendrites of hippocampal CA3 pyramidal neurons", 588, pp.341~345 (1992)
79. "Steroid hormone influences on spatial memory", 743, pp.201~211 (1994)

관련 논문AI추천